Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Type 2 Diabetes Mellitus, Heart Failure, and Chronic Kidney Disease (Last Updated: Nov 7, 2022)
The class of sodium-glucose cotransporter 2 (SGLT2) inhibitors is an integral part of the management of type 2 diabetes. Recent published clinical evidence has provided further guidance on the role of...
Project Line:
Health Technology Review
Project Status:
In Progress